Emilya Huseynova/LinkedIn
Oct 22, 2025, 08:36
Emilya Huseynova to Speak at AABB 2025
Emilya Huseynova, Principal Scientist in Clinical Research at The American Red Cross, shared on LinkedIn:
”Make plans to see me at AABB 2025!
I’m thrilled to share that I am a speaker at the Annual Meeting of the Association for the Advancement of Blood and Biotherapies, taking place Oct 25-28, in San Diego, CA.
Join me for the Plenary Abstract session from 10:00-11:30am on Sun, Oct 26 to learn more about blood safety in a changing environment and explore how we can improve it together.
Find out more about the AABB Annual Meeting here.”
Stay updated with Hemostasis Today.
-
Mar 18, 2026, 12:53Maxime Dely: Why I Took My Toddler to a Blood Donation Session
-
Mar 18, 2026, 12:22Anita Brikman: Advancing Plasma-Derived Therapies in India Through Global Collaboration
-
Mar 18, 2026, 12:17Ben Samelson-Jones: Long-Term Safety and Efficacy of AAV Gene Therapy Using FIX-Padua in Hemophilia B
-
Mar 18, 2026, 12:14Sakditad Saowapa: Optimizing Sexual Activity and Minimizing Infection Risk in Patients with Neutropenia
-
Mar 17, 2026, 18:11Ossama Mansour: Landmark MENA Guidelines for Acute Ischemic Stroke Management
-
Mar 17, 2026, 17:48Andrea Van Beek: Improving DOAC Adherence Saves Lives
-
Mar 17, 2026, 17:43Soumen Bhattacharyya: Microangiopathic Hemolytic Anemia Is Often a Hematologic Clue to Underlying Malignancy
-
Mar 17, 2026, 17:37Peter Bou Dib: New Insights on Factor VIII and the Musculoskeletal System
-
Mar 17, 2026, 17:31Armghan Ans: The 2026 Stroke Guidelines Are Excellent, Now the Hard Part